Une analyse post hoc de l’étude Steno 2 montre que l’approche multifactorielle est associée à une réduction du coût par sujet-année sur les 21,2 ans de suivi (8725€ vs 10.091€, p=0,045) essentiellement par la baisse des hospitalisations pour causes CV. htt
RT @profsmarshall: Up front and free to read in January's issue of @DiabetologiaJnl: A cost analysis of intensified vs conventional multifa…
Up front and free to read in January's issue of @DiabetologiaJnl: A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study by Gæde et al https://t.co/LA5jetxWux http
A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study | SpringerLink https://t.co/VqwbxptAy7
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
RT @moreno_perez_o: A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the…
A cost analysis of intensified vs conventional multifactorial therapy in individuals with T2D: post hoc analysis of the Steno-2 study. the most efficient study in the history of diabetes, “physician 1 - managers with myopia 0” 😉 @sociedadSEEN @SEDiabetes h
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @EstiUgarte: A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analy…
RT @EstiUgarte: A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analy…
RT @EstiUgarte: A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analy…
No se trata de gastar más o menos, se trata de invertir mejor en las intervenciones eficientes. Steno 2 nos lo confirma. Parece que reducir eventos cardiovasculares y mortalidad sale más barato por persona que no hacerlo. Lo tuiteo por si algún gerente...
RT @EstiUgarte: A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analy…
RT @EstiUgarte: A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analy…
RT @EstiUgarte: A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analy…
A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study https://t.co/9WADRkn4yc
A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc… https://t.co/rZjL7ggVg9
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
over 21.2 years of follow-up, the total direct costs of an intensified multifactorial intervention, which led to a disease-free life-length improvement of about 8 years, were similar to those of conventional treatment #steno2
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-risk #T2D. #Diabetes #steno2 @uni_copenhagen @stenodiabetes @NSRsygehus @Metabolcenter https://t.co/WAfgpPT9O1 🔓 #toptweet https://t.co/3
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
No difference in direct medical costs associated with conventional vs intensified treatment in #STENO2 follow up
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
RT @DiabetologiaJnl: 8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-…
8 yrs increased survival at no additional medical costs over 21 yrs with intensified multifactorial treatment in high-risk #T2D. #Diabetes #steno2 @uni_copenhagen @stenodiabetes @NSRsygehus @Metabolcenter https://t.co/WAfgpPBypr 🔓 https://t.co/QLljT1FyP4
RT @drjamesboyle: The total direct costs of an intensified multifactorial intervention, which led to a disease-free life-length improvement…
RT @drjamesboyle: The total direct costs of an intensified multifactorial intervention, which led to a disease-free life-length improvement…
RT @drjamesboyle: The total direct costs of an intensified multifactorial intervention, which led to a disease-free life-length improvement…
RT @drjamesboyle: The total direct costs of an intensified multifactorial intervention, which led to a disease-free life-length improvement…
The total direct costs of an intensified multifactorial intervention, which led to a disease-free life-length improvement of about 8 years, were similar to those of conventional treatment: a post hoc cost analysis of the Steno-2 study now @DiabetologiaJnl